Infante, Jeffrey R.
Cohen, Roger B.
Kim, Kevin B.
Burris, Howard A. III
Curt, Gregory
Emeribe, Ugochi
Clemett, Delyth
Tomkinson, Helen K.
LoRusso, Patricia M.
Funding for this research was provided by:
AstraZeneca
Article History
Received: 21 February 2017
Accepted: 17 March 2017
First Online: 19 April 2017
Change Date: 5 July 2017
Change Type: Erratum
Change Details: An erratum to this article has been published.
Compliance with ethical standards
:
: Author JI declares that he has no conflict of interest. Author RC declares that he has no conflict of interest. Author KK declares that he has no conflict of interest. Author HB declares that he has no conflict of interest. Author GC declares that at the time of the study he was an employee of AstraZeneca and held stock/share options. Author UE declares that he is an employee of AstraZeneca and holds stock/share options. Author HT declares that she is an employee of AstraZeneca and holds stock/share options. Author DC declares that she is a former employee of AstraZeneca and holds stock/share options. Author PL declares that she has no conflict of interest.
: The work was supported by AstraZeneca, Cambridge, UK.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.